News

IEEE5d
Architecture of an augmented reality application for coding and labeling UML class diagrams
Abstract: This article presents an architecture and prototype of the UML-3Dfi application that includes using augmented reality technology for learning the coding and schematization of UML class ...
IEEE14d
Similarity assessment of UML class diagrams using simulated annealing
In this paper, we present the use of Simulated Annealing for matching UML class diagrams based on their lexical, internal, neighborhood similarity, and a combination of them. Additionally the paper ...
The Independent21d
Democrats spending millions to learn how to speak to ‘American Men’ and win back the working class
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
theblock22d
Coinbase sued in class action over stock price drop tied to data breach reveal, alleging disclosure 'omissions'
Coinbase is facing a class action lawsuit filed by stock holders after a recent stock value decline. The exchange disclosed earlier this month that it had suffered a data breach in December, which ...
decrypt22d
Coinbase Faces Investor Lawsuit Over Alleged Damages From Data Breach
The investor took issue with Coinbase's revelation in mid-May that it had suffered a data breach, several months after the leak ... Plaintiff and other Class members have suffered significant losses ...
The New York Times23d
How Donald Trump Has Remade America’s Political Landscape
Republicans are overwhelmingly making gains in working-class counties. Republicans are overwhelmingly making gains in working-class counties. Democrats are improving almost exclusively in ...
PipelineReview.com28d
Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference
KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the presentation of additional preclinical ...
BioSpace28d
NovelMed’s Phase II Data in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Shows Best-in-Class Efficacy as Monotherapy
These interim data demonstrate that Ruxoprubart ... Blood Cells lack protective surface proteins due to a mutation in the phosphatidylinositol glycan class A (PIGA) gene, leaving them vulnerable to ...
Nasdaq28d
Kymera Therapeutics Presents Promising Preclinical Data for KT-621, a First-in-Class Oral STAT6 Degrader, Demonstrating Comparable Efficacy to Dupilumab in Chronic Asthma Model
Kymera Therapeutics has completed its Phase 1 healthy volunteer trials for KT-621, with data to be reported in ... company advancing a new class of oral small molecule degrader medicines for ...
Yahoo Finance28d
NovelMed’s Phase II Data in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Shows Best-in-Class Efficacy as Monotherapy
These interim data demonstrate that Ruxoprubart, administered as monotherapy, was safe, well-tolerated, and met all primary efficacy endpoints. Ruxoprubart achieved transfusion avoidance ...
Yahoo Finance29d
Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference
May 19, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral ... preclinical data for KT-621, its potent ...